发明名称 Dichloroaniline derivatives
摘要 The invention provides compounds of the general formula (I) <IMAGE> (I) wherein X represents a C1-6 alkylene, C2-6 alkenylene or C2-6 alkynylene chain and Y represents a bond, or a C1-4 alkylene, C2-4 alkenylene or C2-4 alkynylene chain with the proviso that the sum total of carbon atoms in X and Y is not more than 8; Ar represents a phenyl group optionally substituted by one or more substituents selected from halogen atoms or the groups C1-3 alkyl, nitro, -(CH2)qR [where R is hydroxy, C1-3 alkoxy, -NR3R4 (where R3 and R4 each represent a hydrogen atom, or a C1-4 alkyl group, or -NR3R4 forms a saturated heterocyclic amino group which has 5-7 ring members and optionally contains in the ring one or more atoms selected from -O- or -S- or a group -NH- or -N(CH3)-), -NR5COR6 (where R5 represents a hydrogen atom or a C1-4 alkyl group, and R6 represents a hydrogen atom or a C1-4 alkyl, C1-4 alkoxy or -NR3R4 group), and q represents an integer from 0 to 3], -NR5COR19 (where R5 is as defined above and R19 represents a phenyl group), -(CH2)r R7 [where R7 represents -NR5SO2R8 (where R8 represents a C1-4 alkyl, phenyl or -NR3R4 group), -NR5COCH2N(R5)2 (where each of the groups R5 represents a hydrogen atom or a C1-4 alkyl group), -COR9 (where R9 represents hydroxy, C1-4 alkoxy or NR3R4), -SR10 (where R10 is a hydrogen atom, or a C1-4 alkyl group optionally substituted by hydroxy, C1-4 alkoxy or NR3R4), -SOR10, -SO2R10, -CN, or -NR11R12 (where R11 and R12 represent a hydrogen atom or a C1-4 alkyl group, at least one of which is C2-4alkyl substituted by a hydroxy, C1-4 alkoxy or NR3R4), and r represents an integer from 0 to 3], -O(CH2)qCOR9 (where q and R9 are as defined above), or -O(CH2)tR13 [where R13 represents hydroxy, NR3R4, NR11R12 or a C1-4 alkoxy group optionally substituted by hydroxy, C1-4 alkoxy or NR3R4, and t is an integer 2 or 3], or Ar is a phenyl group substituted by an alkylenedioxy group -O(CH2)pO- where p is 1 or 2; R1 and R2 each represents a hydrogen atom or a C1-3 alkyl group, with the proviso that the sum total of carbon atoms in R1 and R2 is not more than 4; and physiologically acceptable salts and solvates (e.g. hydrates) thereof. The compounds of formula (I) have a stimulant action at beta 2-adrenoreceptors and are useful, in particular, in the treatment of diseases associated with reversible airways obstruction such as asthma and chronic bronchitis.
申请公布号 US4943591(A) 申请公布日期 1990.07.24
申请号 US19860918317 申请日期 1986.10.14
申请人 GLAXO GROUP LIMITED 发明人 SKIDMORE, IAN F.;LUNTS, LAWRENCE H. C.;FINCH, HARRY;NAYLOR, ALAN;CAMPBELL, IAN B.
分类号 C07C45/00;C07D295/096;C07D295/192 主分类号 C07C45/00
代理机构 代理人
主权项
地址